The global endometriosis treatment market size is expected to reach USD 3.2 billion by 2030. The market is exected to expand at a CAGR of 13.5% from 2023 to 2030. The market growth is attributed to the presence of a late-stage robust product pipeline, the global upsurge in cases, and several initiatives undertaken by the government and key players at national and international levels to raise disease awareness.
The growing research and development for new treatment options in space is expected to offer a lucrative opportunity for market growth in the coming years. The launch of Myovant / Pfizer’s Relugolix combination tablet, ObsEva’s Yselty (linzagolix), and Ferring Pharmaceuticals / Novartis’ Quinagolide are among prominent drug launches in this space that are anticipated to fuel the market growth.
Rising demand for endometriosis treatment is attributed to increasing disease burden and delay in diagnosis, worsening the disease condition. In March 2021, as per WHO, approximately 10% of female reproductive population is affected by the disease worldwide. According to the article, “Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs”, a delay of three or more years in diagnosis from developing first symptom leads to increase in symptom burden and increase in healthcare cost by 50% compared with patients who were diagnosed earlier after symptom onset.
WHO, national governments, and private organizations are strategically involved in spreading awareness and educating people about endometriosis and its treatment, thereby supporting market growth. For instance, in March 2022, the Endometriosis Foundation of America hosted four weekends of the virtual program featuring patients and physicians, helping to connect endometriosis warriors and share their experiences with the disease. Moreover, in March 2022, Endometriosis U.K. also launched an eight-point action plan during the ‘Endometriosis Action Month’.
Furthermore, key players are undertaking strategic initiatives such as mergers and acquisitions, collaborations, financial investments, and geographical expansion fueling the endometriosis treatment market. For instance, in November 2021, Organon and Co. announced to acquire Forendo Pharma, which will support Forendo’s development of novel drugs in endometriosis like OR-6219, a phase 2 clinical candidate.
The growing research and development for new treatment options in space is expected to offer a lucrative opportunity for market growth in the coming years. The launch of Myovant / Pfizer’s Relugolix combination tablet, ObsEva’s Yselty (linzagolix), and Ferring Pharmaceuticals / Novartis’ Quinagolide are among prominent drug launches in this space that are anticipated to fuel the market growth.
Rising demand for endometriosis treatment is attributed to increasing disease burden and delay in diagnosis, worsening the disease condition. In March 2021, as per WHO, approximately 10% of female reproductive population is affected by the disease worldwide. According to the article, “Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs”, a delay of three or more years in diagnosis from developing first symptom leads to increase in symptom burden and increase in healthcare cost by 50% compared with patients who were diagnosed earlier after symptom onset.
WHO, national governments, and private organizations are strategically involved in spreading awareness and educating people about endometriosis and its treatment, thereby supporting market growth. For instance, in March 2022, the Endometriosis Foundation of America hosted four weekends of the virtual program featuring patients and physicians, helping to connect endometriosis warriors and share their experiences with the disease. Moreover, in March 2022, Endometriosis U.K. also launched an eight-point action plan during the ‘Endometriosis Action Month’.
Furthermore, key players are undertaking strategic initiatives such as mergers and acquisitions, collaborations, financial investments, and geographical expansion fueling the endometriosis treatment market. For instance, in November 2021, Organon and Co. announced to acquire Forendo Pharma, which will support Forendo’s development of novel drugs in endometriosis like OR-6219, a phase 2 clinical candidate.
Endometriosis Treatment Market Report Highlights
- By treatment type, the hormone therapy segment accounted for the largest share of the market in 2022 due to the high prescription rate of these drugs by physicians
- Gonadotropin-releasing hormone (GnRH) segment dominated the drug class segment in 2022 due to the high efficacy of GnRH agonists and GnRH antagonists and the increased availability of these products in the market
- In 2022, oral segment dominated the market with a 48.46% share by route of administration. It is the most common & convenient route of delivery for the majority of products in this space
- In 2022, retail pharmacy segment dominatedthe market by distribution channel. Moreover, hospital pharmacy is expected to demonstrate moderate growth
- North America dominated the global market in 2021 owing to increased disease incidence and high awareness among people and healthcare professionals about the condition therapies
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation and Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation and Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Snapshot
2.2 Segment Snapshot
2.3 Competitive Snapshot
Chapter 3 Endometriosis Treatment: Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Landscape
3.4 Market Dynamics
3.5 Market Driver Analysis
3.5.1 Rising disease burden
3.5.2 Growing awareness for the disease
3.5.3 Increasing funding for research and development
3.6 Market Restraint Analysis
3.6.1.1 Availability of over the counter and generic drugs
3.7 PESTEL Analysis
3.8 Industry Analysis - Porter’s Five Forces
3.9 Pipeline Analysis
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory Landscape
3.4 Market Dynamics
3.5 Market Driver Analysis
3.5.1 Rising disease burden
3.5.2 Growing awareness for the disease
3.5.3 Increasing funding for research and development
3.6 Market Restraint Analysis
3.6.1.1 Availability of over the counter and generic drugs
3.7 PESTEL Analysis
3.8 Industry Analysis - Porter’s Five Forces
3.9 Pipeline Analysis
Chapter 4 Endometriosis Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)
4.1 Endometriosis Treatment Market: Treatment Type Movement Analysis
4.2 Pain Medication
4.2.1 Pain Medication Market, 2018 - 2030 (USD Million)
4.3 Hormonal Therapy
4.3.1 Hormonal Therapy Market, 2018 - 2030 (USD Million)
4.2 Pain Medication
4.2.1 Pain Medication Market, 2018 - 2030 (USD Million)
4.3 Hormonal Therapy
4.3.1 Hormonal Therapy Market, 2018 - 2030 (USD Million)
Chapter 5 Endometriosis Treatment Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)
5.1 Endometriosis Treatment: Drug Class Movement Analysis
5.2 NSAIDs
5.2.1 NSAIDs Market, 2018 - 2030 (USD Million)
5.3 Oral Contraceptive
5.3.1 Oral Contraceptive Market, 2018 - 2030 (USD Million)
5.4 Gonadotropin Releasing Hormone
5.4.1 Gonadotropin Releasing Hormone, Market, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others Market, 2018 - 2030 (USD Million)
5.2 NSAIDs
5.2.1 NSAIDs Market, 2018 - 2030 (USD Million)
5.3 Oral Contraceptive
5.3.1 Oral Contraceptive Market, 2018 - 2030 (USD Million)
5.4 Gonadotropin Releasing Hormone
5.4.1 Gonadotropin Releasing Hormone, Market, 2018 - 2030 (USD Million)
5.5 Others
5.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Endometriosis Treatment Market: Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)
6.1 Endometriosis Treatment Market: Route of Administration, Movement Analysis
6.2 Oral
6.2.1 Oral Market, 2018 - 2030 (USD Million)
6.3 Injectable
6.3.1 Injectable Market, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others Market, 2018 - 2030 (USD Million)
6.2 Oral
6.2.1 Oral Market, 2018 - 2030 (USD Million)
6.3 Injectable
6.3.1 Injectable Market, 2018 - 2030 (USD Million)
6.4 Others
6.4.1 Others Market, 2018 - 2030 (USD Million)
Chapter 7 Endometriosis Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
7.1 Endometriosis Treatment Market: Distribution Channel, Movement Analysis
7.2 Hospital pharmacy
7.2.1 Hospital pharmacy Market, 2018 - 2030 (USD Million)
7.3 Retail pharmacy
7.3.1 Retail pharmacy Market, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Others Market, 2018 - 2030 (USD Million)
7.2 Hospital pharmacy
7.2.1 Hospital pharmacy Market, 2018 - 2030 (USD Million)
7.3 Retail pharmacy
7.3.1 Retail pharmacy Market, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Others Market, 2018 - 2030 (USD Million)
Chapter 8 Endometriosis Treatment Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)
8.1 Regional Market Snapshot
8.2 Regional Market Share Analysis, 2021 & 2030
8.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2021 to 2030
8.3.1 North America
8.3.1.1 North America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.1.2 U.S.
8.3.1.2.1 U.S. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.1.3 Canada
8.3.1.3.1 Canada Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2 Europe
8.3.2.1 Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.2 U.K.
8.3.2.2.1 U.K. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.3 Germany
8.3.2.3.1 Germany Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.4 Spain
8.3.2.4.1 Spain Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.5 France
8.3.2.5.1 France Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.6 Italy
8.3.2.6.1 Italy Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.7 Denmark
8.3.2.7.1 Denmark Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.8 Sweden
8.3.2.8.1 Sweden Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.9 Norway
8.3.2.9.1 Norway Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.10 Rest of Europe
8.3.2.10.1 Rest of Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3 Asia Pacific
8.3.3.1 Asia Pacific Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.2 Japan
8.3.3.2.1 Japan Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.3 China
8.3.3.3.1 China Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.4 India
8.3.3.4.1 India Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.5 Australia
8.3.3.5.1 Australia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.6 South Korea
8.3.3.6.1 South Korea Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.7 Thailand
8.3.3.7.1 Thailand Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.8 Rest of APAC
8.3.3.8.1 Rest of APAC Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4 Latin America
8.3.4.1 Latin America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.2 Brazil
8.3.4.2.1 Brazil Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.3 Mexico
8.3.4.3.1 Mexico Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.4 Argentina
8.3.4.4.1 Argentina Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.4 Rest of LATAM
8.3.4.5.1 Rest of LATAM Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5 MEA
8.3.5.1 MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.2 South Africa
8.3.5.2.1 South Africa Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.3 Saudi Arabia
8.3.5.3.1 Saudi Arabia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.4 UAE
8.3.5.4.1 UAE Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.4 Kuwait
8.3.5.4.1 KuwaitEndometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.4 Reso of MEA
8.3.5.4.1 Rest of MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.2 Regional Market Share Analysis, 2021 & 2030
8.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2021 to 2030
8.3.1 North America
8.3.1.1 North America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.1.2 U.S.
8.3.1.2.1 U.S. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.1.3 Canada
8.3.1.3.1 Canada Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2 Europe
8.3.2.1 Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.2 U.K.
8.3.2.2.1 U.K. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.3 Germany
8.3.2.3.1 Germany Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.4 Spain
8.3.2.4.1 Spain Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.5 France
8.3.2.5.1 France Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.6 Italy
8.3.2.6.1 Italy Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.7 Denmark
8.3.2.7.1 Denmark Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.8 Sweden
8.3.2.8.1 Sweden Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.9 Norway
8.3.2.9.1 Norway Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.2.10 Rest of Europe
8.3.2.10.1 Rest of Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3 Asia Pacific
8.3.3.1 Asia Pacific Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.2 Japan
8.3.3.2.1 Japan Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.3 China
8.3.3.3.1 China Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.4 India
8.3.3.4.1 India Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.5 Australia
8.3.3.5.1 Australia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.6 South Korea
8.3.3.6.1 South Korea Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.7 Thailand
8.3.3.7.1 Thailand Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.3.8 Rest of APAC
8.3.3.8.1 Rest of APAC Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4 Latin America
8.3.4.1 Latin America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.2 Brazil
8.3.4.2.1 Brazil Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.3 Mexico
8.3.4.3.1 Mexico Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.4 Argentina
8.3.4.4.1 Argentina Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.4.4 Rest of LATAM
8.3.4.5.1 Rest of LATAM Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5 MEA
8.3.5.1 MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.2 South Africa
8.3.5.2.1 South Africa Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.3 Saudi Arabia
8.3.5.3.1 Saudi Arabia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.4 UAE
8.3.5.4.1 UAE Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.4 Kuwait
8.3.5.4.1 KuwaitEndometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
8.3.5.4 Reso of MEA
8.3.5.4.1 Rest of MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 9 Endometriosis Treatment Market: Competitive Analysis
9.1 Strategic Initiatives and Impact Analysis, by Key Market Participants
9.1.1 Synergy Analysis: Major Deals and Strategic Alliances
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Licensing Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End-Users
9.4.3 Key Company Market Share Analysis, 2021
9.4.4 Consumer Behavior Analysis
9.4.5 Competitive Dashboard Analysis
9.5 Private Companies
9.5.1 List of Key Emerging Companies
9.5.2 Regional Network Map
9.6 Company Profiles
9.6.1 Bayer AG
9.6.1.1 Company Overview
9.6.1.2 Financial Performance
9.6.1.3 Product Benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Pfizer, Inc
9.6.2.1 Company Overview
9.6.2.2 Financial Performance
9.6.2.3 Product Benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 AbbVie, Inc
9.6.3.1 Company Overview
9.6.3.2 Financial Performance
9.6.3.3 Product Benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 AstraZeneca
9.6.4.1 Company Overview
9.6.4.2 Financial Performance
9.6.4.3 Product Benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 ObsEva SA
9.6.5.1 Company Overview
9.6.5.2 Financial Performance
9.6.5.3 Product Benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Teva Pharmaceutical Industries
9.6.6.1 Company Overview
9.6.6.2 Financial Performance
9.6.6.3 Product Benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 Zydus Healthcare Limited
9.6.7.1 Company Overview
9.6.7.2 Financial performance
9.6.7.3 Product Benchmarking
9.6.7.4 Strategic Initiatives
9.6.8 Eli Lilly and Company
9.6.8.1 Company Overview
9.6.8.2 Financial performance
9.6.8.3 Product Benchmarking
9.6.8.4 Strategic Initiatives
9.6.9 Astellas Pharma Inc
9.6.9.1 Company Overview
9.6.9.2 Financial performance
9.6.9.3 Product Benchmarking
9.6.9.4 Strategic Initiatives
9.1.1 Synergy Analysis: Major Deals and Strategic Alliances
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Licensing Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End-Users
9.4.3 Key Company Market Share Analysis, 2021
9.4.4 Consumer Behavior Analysis
9.4.5 Competitive Dashboard Analysis
9.5 Private Companies
9.5.1 List of Key Emerging Companies
9.5.2 Regional Network Map
9.6 Company Profiles
9.6.1 Bayer AG
9.6.1.1 Company Overview
9.6.1.2 Financial Performance
9.6.1.3 Product Benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Pfizer, Inc
9.6.2.1 Company Overview
9.6.2.2 Financial Performance
9.6.2.3 Product Benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 AbbVie, Inc
9.6.3.1 Company Overview
9.6.3.2 Financial Performance
9.6.3.3 Product Benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 AstraZeneca
9.6.4.1 Company Overview
9.6.4.2 Financial Performance
9.6.4.3 Product Benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 ObsEva SA
9.6.5.1 Company Overview
9.6.5.2 Financial Performance
9.6.5.3 Product Benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Teva Pharmaceutical Industries
9.6.6.1 Company Overview
9.6.6.2 Financial Performance
9.6.6.3 Product Benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 Zydus Healthcare Limited
9.6.7.1 Company Overview
9.6.7.2 Financial performance
9.6.7.3 Product Benchmarking
9.6.7.4 Strategic Initiatives
9.6.8 Eli Lilly and Company
9.6.8.1 Company Overview
9.6.8.2 Financial performance
9.6.8.3 Product Benchmarking
9.6.8.4 Strategic Initiatives
9.6.9 Astellas Pharma Inc
9.6.9.1 Company Overview
9.6.9.2 Financial performance
9.6.9.3 Product Benchmarking
9.6.9.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 List of Parameters
Table 4 List of Distributors
Table 5 Global Endometriosis Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 Global Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 10 North America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 12 North America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Europe Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 24 Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 25 Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 26 Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 27 Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 Germany Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 29 Germany Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 30 Germany Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 Germany Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 U.K. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 33 U.K. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 34 U.K. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 U.K. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 France Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 37 France Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 38 France Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 39 France Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Italy Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 41 Italy Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 42 Italy Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Italy Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Spain Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 45 Spain Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 46 Spain Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 47 Spain Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Denmark Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 49 Denmark Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 50 Denmark Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 51 Denmark Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Sweden Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 53 Sweden Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 54 Sweden Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 Sweden Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 Norway Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 57 Norway Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 58 Norway Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 59 Norway Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 61 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 62 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 68 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 69 Japan Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 70 Japan Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 71 Japan Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 72 Japan Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 73 China Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 74 China Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 75 China Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 China Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 77 India Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 78 India Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 79 India Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 80 India Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 81 South Korea Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 82 South Korea Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 83 South Korea Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 South Korea Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 85 Australia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 86 Australia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 87 Australia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 88 Australia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 89 Thailand Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 90 Thailand Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 91 Thailand Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 92 Thailand Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 93 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 94 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 95 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 97 Latin America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 98 Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 99 Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 100 Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 101 Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 102 Brazil Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 103 Brazil Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 104 Brazil Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 105 Brazil Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 106 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 107 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 108 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 109 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 110 Argentina Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 111 Argentina Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 112 Argentina Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 113 Argentina Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 114 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 115 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 116 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 118 Middle East & Africa Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 119 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 120 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 121 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 122 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 123 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 124 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 126 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 127 South Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 128 South Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 129 South Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 130 South Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 131 UAE Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 132 UAE Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 133 UAE Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 134 UAE Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 135 Kuwait Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 136 Kuwait Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 137 Kuwait Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 138 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 139 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 140 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 141 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 142 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 2 List of Abbreviation
Table 3 List of Parameters
Table 4 List of Distributors
Table 5 Global Endometriosis Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 Global Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 10 North America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 12 North America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Europe Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 24 Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 25 Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 26 Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 27 Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 28 Germany Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 29 Germany Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 30 Germany Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 31 Germany Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 32 U.K. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 33 U.K. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 34 U.K. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 U.K. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 36 France Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 37 France Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 38 France Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 39 France Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Italy Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 41 Italy Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 42 Italy Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 43 Italy Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Spain Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 45 Spain Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 46 Spain Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 47 Spain Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Denmark Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 49 Denmark Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 50 Denmark Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 51 Denmark Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 52 Sweden Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 53 Sweden Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 54 Sweden Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 Sweden Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 56 Norway Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 57 Norway Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 58 Norway Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 59 Norway Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 61 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 62 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 68 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 69 Japan Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 70 Japan Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 71 Japan Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 72 Japan Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 73 China Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 74 China Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 75 China Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 China Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 77 India Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 78 India Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 79 India Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 80 India Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 81 South Korea Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 82 South Korea Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 83 South Korea Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 South Korea Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 85 Australia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 86 Australia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 87 Australia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 88 Australia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 89 Thailand Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 90 Thailand Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 91 Thailand Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 92 Thailand Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 93 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 94 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 95 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 97 Latin America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 98 Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 99 Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 100 Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 101 Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 102 Brazil Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 103 Brazil Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 104 Brazil Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 105 Brazil Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 106 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 107 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 108 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 109 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 110 Argentina Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 111 Argentina Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 112 Argentina Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 113 Argentina Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 114 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 115 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 116 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 118 Middle East & Africa Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 119 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 120 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 121 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 122 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 123 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 124 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 126 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 127 South Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 128 South Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 129 South Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 130 South Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 131 UAE Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 132 UAE Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 133 UAE Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 134 UAE Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 135 Kuwait Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 136 Kuwait Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 137 Kuwait Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 138 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 139 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
Table 140 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 141 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 142 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Endometriosis Treatment Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Commodity Flow Approach
Fig. 10 Market Snapshot (2022) (USD Million)
Fig. 11 Segment Snapshot (2022) (USD Million)
Fig. 12 Competitive Snapshot
Fig. 13 Penetration & Growth Prospect Mapping
Fig. 14 Endometriosis Treatment Market Driver Impact
Fig. 15 Endometriosis Treatment Market Restraint Impact
Fig. 16 PESTEL Analysis
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 Endometriosis Treatment, Treatment Type Outlook: Key Takeaways
Fig. 19 Endometriosis Treatment Market: Treatment Type Movement Analysis (USD Million)
Fig. 20 Pain Medication Market 2018 - 2030 (USD Million)
Fig. 21 Hormone Therapy Market, 2018 - 2030 (USD Million)
Fig. 22 Endometriosis Treatment Market: Drug Class Movement Analysis (USD Million)
Fig. 23 NSAIDs Market, 2018 - 2030 (USD Million)
Fig. 24 Oral Contraceptive, Market, 2018 - 2030 (USD Million)
Fig. 25 Progestin Market, 2018 - 2030 (USD Million)
Fig. 26 Gonadotropin Releasing Hormone Market, 2018 - 2030 (USD Million)
Fig. 27 Danazol Market, 2018 - 2030 (USD Million)
Fig. 28 Others Market, 2018 - 2030 (USD Million)
Fig. 29 Endometriosis Treatment, Route of Administartion Outlook: Key Takeaways
Fig. 30 Endometriosis Treatment Market: Route of Administartion Movement Analysis (USD Million)
Fig. 31 Oral Market, 2018 - 2030 (USD Million)
Fig. 32 Injectable Market, 2018 - 2030 (USD Million)
Fig. 33 Others Market, 2018 - 2030 (USD Million)
Fig. 34 Endometriosis Treatment Market Distribution Channel Outlook: Key Takeaways
Fig. 35 Hospital pharmacy Market, 2018 - 2030 (USD Million)
Fig. 36 Retail pharmacy Market, 2018 - 2030 (USD Million)
Fig. 37 Others Market, 2018 - 2030 (USD Million)
Fig. 38 Regional Snapshot, 2021 & 2030
Fig. 39 Regional Market Place: Key takeaways
Fig. 40 North America
Fig. 41 North America Endometriosis Treatment Market, 2018 - 2030 (USD million)
Fig. 42 U.S.
Fig. 43 U.S. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 44 Canada
Fig. 45 Canada Endometriosis Treatment Market, 2018 - 2030 (USD million)
Fig. 46 Europe
Fig. 47 Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 48 U.K.
Fig. 49 U.K. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 50 Germany
Fig. 51 Germany Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 52 Spain
Fig. 53 Spain Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 54 France
Fig. 55 France Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Italy
Fig. 57 Italy Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Denmark
Fig. 57 Denmark Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Sweden
Fig. 57 Sweden Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Norway
Fig. 57 Norway Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Rest of Europe
Fig. 57 Rest of Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific
Fig. 59 Asia Pacific Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 60 Japan
Fig. 61 Japan Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 62 China
Fig. 63 China Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 64 India
Fig. 65 India Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 66 Australia
Fig. 67 Australia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 68 South Korea
Fig. 69 South Korea Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 70 Thailand
Fig. 71 Thailand Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 72 Rest of APAC
Fig. 73 Rest of APAC Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 74 Latin America
Fig. 75 Latin America Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 76 Brazil
Fig. 77 Brazil Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 78 Mexico
Fig. 79 Mexico Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 80 Argentina
Fig. 81 Argentina Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 82 Rest of LATAM
Fig. 83 Rest of LATAM Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 84 Middle East & Africa
Fig. 85 MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 86 South Africa
Fig. 87 South Africa Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia
Fig. 89 Saudi Arabia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 90 UAE
Fig. 91 UAE Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 92 Kuwait
Fig. 93 Kuwait Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 94 Rest of MEA
Fig. 95 Rest of MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 96 Heat Map Analysis
Fig. 97 Company Market Position Analysis, 2021
Fig. 98 Company Market Position Analysis, 2021
Fig. 99 Company Market Share Analysis (2021)
Fig. 100 Consumer Behavior Analysis
Fig. 101 Market Differentiators
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Commodity Flow Approach
Fig. 10 Market Snapshot (2022) (USD Million)
Fig. 11 Segment Snapshot (2022) (USD Million)
Fig. 12 Competitive Snapshot
Fig. 13 Penetration & Growth Prospect Mapping
Fig. 14 Endometriosis Treatment Market Driver Impact
Fig. 15 Endometriosis Treatment Market Restraint Impact
Fig. 16 PESTEL Analysis
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 Endometriosis Treatment, Treatment Type Outlook: Key Takeaways
Fig. 19 Endometriosis Treatment Market: Treatment Type Movement Analysis (USD Million)
Fig. 20 Pain Medication Market 2018 - 2030 (USD Million)
Fig. 21 Hormone Therapy Market, 2018 - 2030 (USD Million)
Fig. 22 Endometriosis Treatment Market: Drug Class Movement Analysis (USD Million)
Fig. 23 NSAIDs Market, 2018 - 2030 (USD Million)
Fig. 24 Oral Contraceptive, Market, 2018 - 2030 (USD Million)
Fig. 25 Progestin Market, 2018 - 2030 (USD Million)
Fig. 26 Gonadotropin Releasing Hormone Market, 2018 - 2030 (USD Million)
Fig. 27 Danazol Market, 2018 - 2030 (USD Million)
Fig. 28 Others Market, 2018 - 2030 (USD Million)
Fig. 29 Endometriosis Treatment, Route of Administartion Outlook: Key Takeaways
Fig. 30 Endometriosis Treatment Market: Route of Administartion Movement Analysis (USD Million)
Fig. 31 Oral Market, 2018 - 2030 (USD Million)
Fig. 32 Injectable Market, 2018 - 2030 (USD Million)
Fig. 33 Others Market, 2018 - 2030 (USD Million)
Fig. 34 Endometriosis Treatment Market Distribution Channel Outlook: Key Takeaways
Fig. 35 Hospital pharmacy Market, 2018 - 2030 (USD Million)
Fig. 36 Retail pharmacy Market, 2018 - 2030 (USD Million)
Fig. 37 Others Market, 2018 - 2030 (USD Million)
Fig. 38 Regional Snapshot, 2021 & 2030
Fig. 39 Regional Market Place: Key takeaways
Fig. 40 North America
Fig. 41 North America Endometriosis Treatment Market, 2018 - 2030 (USD million)
Fig. 42 U.S.
Fig. 43 U.S. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 44 Canada
Fig. 45 Canada Endometriosis Treatment Market, 2018 - 2030 (USD million)
Fig. 46 Europe
Fig. 47 Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 48 U.K.
Fig. 49 U.K. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 50 Germany
Fig. 51 Germany Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 52 Spain
Fig. 53 Spain Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 54 France
Fig. 55 France Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Italy
Fig. 57 Italy Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Denmark
Fig. 57 Denmark Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Sweden
Fig. 57 Sweden Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Norway
Fig. 57 Norway Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 56 Rest of Europe
Fig. 57 Rest of Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific
Fig. 59 Asia Pacific Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 60 Japan
Fig. 61 Japan Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 62 China
Fig. 63 China Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 64 India
Fig. 65 India Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 66 Australia
Fig. 67 Australia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 68 South Korea
Fig. 69 South Korea Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 70 Thailand
Fig. 71 Thailand Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 72 Rest of APAC
Fig. 73 Rest of APAC Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 74 Latin America
Fig. 75 Latin America Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 76 Brazil
Fig. 77 Brazil Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 78 Mexico
Fig. 79 Mexico Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 80 Argentina
Fig. 81 Argentina Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 82 Rest of LATAM
Fig. 83 Rest of LATAM Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 84 Middle East & Africa
Fig. 85 MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 86 South Africa
Fig. 87 South Africa Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia
Fig. 89 Saudi Arabia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 90 UAE
Fig. 91 UAE Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 92 Kuwait
Fig. 93 Kuwait Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 94 Rest of MEA
Fig. 95 Rest of MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
Fig. 96 Heat Map Analysis
Fig. 97 Company Market Position Analysis, 2021
Fig. 98 Company Market Position Analysis, 2021
Fig. 99 Company Market Share Analysis (2021)
Fig. 100 Consumer Behavior Analysis
Fig. 101 Market Differentiators
Companies Mentioned
- Bayer AG
- Pfizer, Inc
- Abbvie, Inc
- Astrazeneca
- Obseva Sa
- Teva Pharmaceutical Industries
- Zydus Healthcare Limited
- Eli Lilly and Company
- Astellas Pharma Inc
Methodology
LOADING...
